Quotient Sciences Capabilities Update March 2026: Small Molecule Drug Product

Quotient Sciences is a clinical development and manufacturing accelerator providing integrated services across the entire development pathway. From drug product formulation development, through clinical and commercial manufacturing, as well as a full range of early clinical development programs and clinical pharmacology studies (DDI, SAD/MAD, human ADME, and more.

Translational Pharmaceutics® brings CRO and CDMO activities together into a single, integrated program delivered under a single project manager. This unified approach removes traditional hand-offs, enabling faster clinical decision-making and, in many cases, reducing development timelines by up to 12 months. Translational Pharmaceutics® reduces API consumption, simplifies supply chain activities, and enables a range of drug product prototypes to be manufactured and dosed within a single human trial. In addition, we integrate development services as part of our flagship platform: Translational Pharmaceutics®.

In our presentation, hear more about Translational Pharmaceutics® and how we apply it to programs conducted in either the U.S. or the U.K. to help our clients ensure more successful outcomes while reducing development timelines. We will highlight real examples, including a complex modified‑release program where rapid formulation adjustment, enabled by adaptive GMP manufacturing, allowed a sponsor to evaluate variables such as release rate, dose, and IR/ER ratios without adding development delays.

This session is designed to help you assess which development approaches, locations, and timelines may be most appropriate for your asset today. You’ll learn:

• How integrated development activities accelerate clinical decision-making and reduce overall timelines
• How Translational Pharmaceutics® programs are executed across Quotient’s U.S. and U.K. facilities, and what that means for development planning
• Practical insights from real client case studies to help you assess potential development and manufacturing options for your program